# Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD

> **NCT02074228** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Attention-deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate (Concerta)

## Key facts

- **NCT ID:** NCT02074228
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02074228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02074228, "Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02074228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*